BioWorld MedTech

Aug. 27, 2010

Deals roundup: Novartis buys majority stake in Alcon for $23.3B

Novartis (Basel, Switzerland) and Nestlé (Vevey, Switzerland) say they have completed the purchase and sale of nearly 156 million shares of Alcon (Huenenberg, Switzerland) for $28.3 billion in cash. (Medical Device Daily) Read More

TRT enlists 'soft' shock wave to help heal tissue

International report: Medtronic receives Canadian okay for RF ablation system

FDA publishes draft guidance for benign prostatic hyperplasia

Washington roundup: Atlanta's St. Joe's hospital certified for VAD implant

MDD's food for med-tech thought

Financings roundup: Cardiac Concepts grabs $27M for sleep apnea pacing device

People in the News

Agreements/contracts: Lockheed Martin, HHS support health information

Med-Tech Notes

Product Briefs

DePuy Ortho voluntarily recalls ASR hip system

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for April 8, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 8, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

Many med-tech company supply chains protected from tariffs

BioWorld MedTech

In the wake of the pandemic, many leading med-tech companies took steps to on-shore and near-shore manufacturing, a move that could protect significant numbers of...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...